Transthyretin IIe 122 and cardiac amyloidosis in African-Americans: 2 case reports

Texas Heart Institute Journal

Volumn 24, Issue 1, 1997, Pages 45-52

  Jacobson, Daniel R ^a,d   Ittmann, Michael ^a   Buxbaum, Joel N ^a   Wieczorek, Rosemary ^a   Gorevic, Peter D ^b,c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d New York City Medical Center   (United States)

Author keywords

African Americans genetics; amyloidosis diagnosis; amyloidosis ethnology; amyloidosis ge netics; congestive; heart conduction system physiopathology; heart diseases etiology; heart failure; isoleucine genetics; prealbumin transthyretin; variation (genetics)

Indexed keywords

PREALBUMIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; AUTOPSY; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAM; HEART AMYLOIDOSIS; HISTOPATHOLOGY; HUMAN; MALE; NEGRO; ALLELE; AMYLOIDOSIS; CARDIOMYOPATHY; ELECTROCARDIOGRAPHY; FATALITY; GENETIC VARIABILITY; GENETICS; HEART MUSCLE; PATHOLOGY; POINT MUTATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALLELES; AMYLOIDOSIS; CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; FATAL OUTCOME; HUMANS; MALE; MYOCARDIUM; POINT MUTATION; PREALBUMIN; VARIATION (GENETICS);

EID: 0030615175     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Roberts WC, Waller BF. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol 1983;52:137-46
2. Jacobson DR, Buxbaum JN. Genetic aspects of amyloidosis. Adv Hum Genet 1991;20:69-123.
3. Husby G. Nomenclature and classification of amyloid and amyloidoses. J Intern Med 1992;232:511-2.
4. Pitkänen P, Westermark P, Cornwell GG III Senile systemic amyloidosis. Am J Pathol 1984;117:391-9
5. Saraiva MJM Transthyretin mutations in health and disease. Hum Mutat 1995;5:191-6.
6. Jacobson DR, Pastore R, Poos S, Malendowicz S, Kane I, Shivji A, et al. Revised transthyretin Ile 122 allele frequency in African-Americans. Hum Genet 1996,98:236-8.
7. Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B. Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 1989;83:836-43.
8. Jacobson DR A specific test for transthyretin 122 (Val→Ile), based on PCR-primer-introduced restriction analysis (PCR-PIRA), confirmation of the gene frequency in blacks. Am J Hum Genet 1992;50:195-8.
9. Nichols WC, Liepnieks JJ, Snyder EL, Benson MD. Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). J Lab Clin Med 1991;117:175-80.
10. Saraiva MJM, Sherman W, Marboe C, Figueira A, Costa P, de Freitas AF, et al. Cardiac amyloidosis: report of a patient heterozygous for the transthyretin isoleucine 122 variant. Scand J Immunol 1990;32:341-6.
11. Buja LM, Khoi NB, Roberts WC. Clinically significant cardiac amyloidosis. Clinicopathologic findings in 15 patients. Am J Cardiol 1970;26:394-405.
12. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, et al Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
13. Skare J, Yazici H, Erken E, Dede H, Cohen A, Milunsky A, et al. Homozygosity for the met30 transthyretin gene in a Turkish kindred with familial amyloidotic polyneuropathy. Hum Genet 1990;86:89-90
14. Holmgren G, Bergström S, Drugge U, Lundgren E, Nording-Sikstrom C, Sandgren O, et al. Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences. Clin Genet 1992;41:39-41.
15. Olson LJ, Gertz MA, Edwards WD, Li CY, Pellika PA, Holmes DR Jr, et al. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med 1987;317:738-42.
16. Skinner M, Anderson JJ, Simms R, Falk R, Wang M, Libbey C, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 1996;100:290-8.
17. Simons M, Isner JM. Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis. Am J Cardiol 1992;69:425-7
18. Beckman A, Bjerle P, Olofsson B-O. Electrocardiographic findings in familial amyloidotic polyneuropathy. Am J Noninvas Cardiol 1992;6:192-6.
19. Hartmann A, Frenkel J, Hopf R, Baum RP, Hor G, Schneider M, et al. Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis? Int J Card Imaging 1990;5:227-31
20. Rubinow A, Skinner M, Cohen AS. Digoxin sensitivity in amyloid cardiomyopathy Circulation 1981;63:1285-8.
21. Brandt K, Cathcart ES, Cohen AS. A clinical analysis of the course and prognosis of forty-two patients with amyloidosis. Am J Med 1968;44:955-69.
22. Gertz MA, Skinner M, Connors LH, Falk RH, Cohen AS, Kyle RA. Selective binding of nifedipine to amyloid fibrils. Am J Cardiol 1985;55(13 Pt 1):1646.
23. Gertz MA, Falk RH, Skinner M, Cohen AS, Kyle RA. Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents. Am J Cardiol 1985;55(13 Pt 1):1645.
24. Griffiths BE, Hughes P, Dowdle R, Stephens MR. Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine. Thorax 1982;37:711-2.
25. Kyle RA, Gertz MA, Linke RP Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type. Am J Clin Pathol 1992;97:250-3
26. Skinner M, Harding J, Skare I, Jones LA, Cohen AS, Milunsky A, et al. A new transthyretin mutation associated with amyloidotic vitreous opacities. Asparagine for isoleucine at position 84. Ophthalmology 1992;99:503-8
27. Gertz MA, Li CY, Shirahama T, Kyle RA. Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain). Arch Intern Med 1988;148: 929-33.
28. Maruyama K, Ikeda S, Yanagisawa N, Nakazato M. Diagnostic value of abdominal fat tissue aspirate in familial amyloid polyneuropathy. J Neurol Sci 1987;81:11-8.
29. Skinner M, Lewis WD, Jones LA, Kasirsky J, Kane K, Ju ST, et al. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med 1994;120:133-4.
30. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997;336:466-73.